Related Experiment Videos
Polycythemia and hyperviscosity of the newborn
1Neonatal Intensive Care Unit, University of Washington Medical Center, Seattle, Wash., USA. lgordon@u.washington.edu
The Journal of Perinatal & Neonatal Nursing
|September 10, 2003
Summary
Polycythemia and hyperviscosity in newborns, particularly term infants, often present subtly. Early identification relies on understanding causes, symptoms, and pathophysiology for timely intervention.
Area of Science:
- Neonatal Medicine
- Pediatric Hematology
Background:
- Polycythemia and hyperviscosity are recognized neonatal conditions with ongoing controversy.
- Term and near-term infants are the primary population affected.
- The actual incidence is unknown, as many infants are asymptomatic.
Purpose of the Study:
- To highlight the importance of understanding the etiology, pathophysiology, and clinical signs of polycythemia and hyperviscosity syndrome.
- To emphasize the need for early identification and treatment in affected newborns.
Main Methods:
- Diagnosis primarily relies on hematocrit values and clinical symptoms.
- Viscosity measurements are not routinely used for diagnosis.
- Hematocrit levels are not consistently monitored due to treatment controversies.
Main Results:
- Symptoms can be subtle and may not be immediately attributed to polycythemia.
- Asymptomatic infants often represent the majority of cases.
- Current diagnostic and treatment approaches are debated.
Conclusions:
- Increased awareness of polycythemia and hyperviscosity syndrome is crucial.
- Knowledge of the condition's mechanisms and manifestations aids early detection.
- Prompt identification and management can improve outcomes for affected newborns.